focus -WSS

focus

author：knowledge 2025-09-05 05:54:40 - browse：76652

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Histogen: Failed biotech offers rare public look inside

hotspot

WSS

VC firm General Catalyst wants to buy a health system

What we’ve learned from the Aduhelm mess

Chan Zuckerberg Biohub Chicago to focus on inflammation

BioAge raises $170M for combination therapy with Zepbound

Colorectal cancer study finds potential in overlooked immune cell

Chan Zuckerberg Biohub Chicago to focus on inflammation

hotspot

focus

focus

Tori Bowie and the unacceptable rates of Black maternal death

Senators start work on Medicare physician payment reform

Supreme Court strikes down use of affirmative action

Chemotherapy drug shortage eases slightly but still widespread

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The Readout: Gilead, Bernie Sanders, and other pharma news

Tori Bowie and the unacceptable rates of Black maternal death

Phenylephrine and the overlooked value of the placebo effect

Novavax promises a turnaround & Lilly roils the obesity market

Why Charlie Gard's case is so disturbing to Americans

hotspot

Physician executives need more than on

Histogen: Failed biotech offers rare public look inside

Analysis of telehealth claims data suggest service duplication

Medical mystery: When a cough is not just a cough

Robert F. Kennedy is pitching centrism on health, even on abortion

The dental labor crisis is a moment of opportunity

Wikipedia

hotspot

explore

Wikipedia